HRP20000703B1 - Stabile compositions levosimendan and alginic acid - Google Patents

Stabile compositions levosimendan and alginic acid

Info

Publication number
HRP20000703B1
HRP20000703B1 HR20000703A HRP20000703A HRP20000703B1 HR P20000703 B1 HRP20000703 B1 HR P20000703B1 HR 20000703 A HR20000703 A HR 20000703A HR P20000703 A HRP20000703 A HR P20000703A HR P20000703 B1 HRP20000703 B1 HR P20000703B1
Authority
HR
Croatia
Prior art keywords
levosimendan
alginic acid
stabile
compositions
stabile compositions
Prior art date
Application number
HR20000703A
Other languages
English (en)
Croatian (hr)
Inventor
Larma Ilkka
Backman Maarit
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of HRP20000703A2 publication Critical patent/HRP20000703A2/hr
Publication of HRP20000703B1 publication Critical patent/HRP20000703B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HR20000703A 1998-04-23 2000-10-19 Stabile compositions levosimendan and alginic acid HRP20000703B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI980902A FI980902A (fi) 1998-04-23 1998-04-23 Levosimendaanin stabiileja koostumuksia
PCT/FI1999/000331 WO1999055337A1 (en) 1998-04-23 1999-04-23 Stabile compositions comprising levosimendan and alginic acid

Publications (2)

Publication Number Publication Date
HRP20000703A2 HRP20000703A2 (en) 2001-04-30
HRP20000703B1 true HRP20000703B1 (en) 2009-11-30

Family

ID=8551576

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20000703A HRP20000703B1 (en) 1998-04-23 2000-10-19 Stabile compositions levosimendan and alginic acid

Country Status (33)

Country Link
US (1) US6531458B1 (id)
EP (1) EP1079834B1 (id)
JP (1) JP4475809B2 (id)
KR (1) KR100590622B1 (id)
CN (1) CN1165309C (id)
AT (1) ATE231395T1 (id)
AU (1) AU756338B2 (id)
BG (1) BG64766B1 (id)
BR (1) BR9909867A (id)
CA (1) CA2329232C (id)
CZ (1) CZ290911B6 (id)
DE (1) DE69905034T2 (id)
DK (1) DK1079834T3 (id)
EA (1) EA002428B1 (id)
EE (1) EE04143B1 (id)
ES (1) ES2191426T3 (id)
FI (1) FI980902A (id)
GE (1) GEP20032942B (id)
HK (1) HK1031998A1 (id)
HR (1) HRP20000703B1 (id)
HU (1) HUP0105446A3 (id)
ID (1) ID26650A (id)
IL (2) IL138950A0 (id)
MX (1) MXPA00010368A (id)
NO (1) NO318575B1 (id)
NZ (1) NZ507455A (id)
PL (1) PL192274B1 (id)
PT (1) PT1079834E (id)
RS (1) RS49955B (id)
SK (1) SK284600B6 (id)
TR (1) TR200003101T2 (id)
WO (1) WO1999055337A1 (id)
ZA (1) ZA200005630B (id)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980901A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
WO2002064120A1 (fr) * 2001-02-13 2002-08-22 Taisho Pharmaceutical Co., Ltd. Preparations de gel a usage interne
EP1858518A1 (en) * 2005-03-14 2007-11-28 Orion Corporation A combination treatment for enhancing diuresis
EP3370693B1 (en) * 2015-11-06 2020-01-08 Carinopharm GmbH Improved formulations of levosimendan for intravenous administration as infusion or injection and of infusion concentrate
EP4076398A4 (en) 2019-12-16 2024-01-03 Tenax Therapeutics, Inc. LEVOSIMENDAN TO TREAT PULMONARY HYPERTENSION ACCOMPANIED BY HEART FAILURE BY MEANS OF PRESERVED EJECTION FRACTION (PH-HF-PEF)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0091767A2 (en) * 1982-04-05 1983-10-19 Merck Sharp & Dohme Ltd. Stabilization of unstable drugs or food supplements
US4716042A (en) * 1986-06-16 1987-12-29 American Home Products Corporation Stabilized coated aspirin tablets
WO1992012135A1 (en) * 1991-01-03 1992-07-23 Orion-Yhtymä Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile
WO1998001111A1 (en) * 1996-07-05 1998-01-15 Orion-Yhtymä Oy Transdermal compositions containing levosimendan
WO1999016443A1 (en) * 1997-09-26 1999-04-08 Orion Corporation Oral compositions of levosimendan

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
EP0123291A2 (en) 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Method for stabilizing interferon
US4906630A (en) * 1985-11-22 1990-03-06 Rorer Pharmaceutical Corporation Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0091767A2 (en) * 1982-04-05 1983-10-19 Merck Sharp & Dohme Ltd. Stabilization of unstable drugs or food supplements
US4716042A (en) * 1986-06-16 1987-12-29 American Home Products Corporation Stabilized coated aspirin tablets
WO1992012135A1 (en) * 1991-01-03 1992-07-23 Orion-Yhtymä Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile
WO1998001111A1 (en) * 1996-07-05 1998-01-15 Orion-Yhtymä Oy Transdermal compositions containing levosimendan
WO1999016443A1 (en) * 1997-09-26 1999-04-08 Orion Corporation Oral compositions of levosimendan

Also Published As

Publication number Publication date
BG64766B1 (bg) 2006-03-31
CN1165309C (zh) 2004-09-08
PL343722A1 (en) 2001-09-10
HUP0105446A3 (en) 2002-09-30
YU64000A (sh) 2002-12-10
NO20005312L (no) 2000-11-21
FI980902A (fi) 1999-10-24
CN1298303A (zh) 2001-06-06
DE69905034D1 (de) 2003-02-27
US6531458B1 (en) 2003-03-11
AU3524899A (en) 1999-11-16
MXPA00010368A (es) 2002-07-02
BR9909867A (pt) 2000-12-19
PL192274B1 (pl) 2006-09-29
FI980902A0 (fi) 1998-04-23
ES2191426T3 (es) 2003-09-01
HRP20000703A2 (en) 2001-04-30
CZ20003779A3 (en) 2001-05-16
JP2002512964A (ja) 2002-05-08
ZA200005630B (en) 2002-01-14
EE04143B1 (et) 2003-10-15
NO20005312D0 (no) 2000-10-20
EP1079834A1 (en) 2001-03-07
EP1079834B1 (en) 2003-01-22
IL138950A0 (en) 2001-11-25
ATE231395T1 (de) 2003-02-15
NO318575B1 (no) 2005-04-11
PT1079834E (pt) 2003-04-30
DE69905034T2 (de) 2003-09-04
RS49955B (sr) 2008-09-29
GEP20032942B (en) 2003-04-25
EA002428B1 (ru) 2002-04-25
IL138950A (en) 2006-08-20
SK15552000A3 (sk) 2001-05-10
AU756338B2 (en) 2003-01-09
WO1999055337A1 (en) 1999-11-04
BG104958A (en) 2001-07-31
JP4475809B2 (ja) 2010-06-09
CA2329232A1 (en) 1999-11-04
HK1031998A1 (en) 2001-07-06
CA2329232C (en) 2007-10-30
EE200000616A (et) 2002-06-17
TR200003101T2 (tr) 2001-01-22
SK284600B6 (sk) 2005-07-01
KR100590622B1 (ko) 2006-06-19
ID26650A (id) 2001-01-25
DK1079834T3 (da) 2003-04-07
KR20010072577A (ko) 2001-07-31
NZ507455A (en) 2002-02-01
CZ290911B6 (cs) 2002-11-13
EA200001097A1 (ru) 2001-04-23
HUP0105446A2 (hu) 2002-07-29

Similar Documents

Publication Publication Date Title
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
DE69928938D1 (de) Neues cyclosporin mit verbesserter wirkung
BG106030A (en) Pharmaceutical composition
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
DE69817208D1 (de) Saure, verdickte reinigungs- bzw. desinfektionszusammensetzung
EE200000759A (et) Farmatseutilised kompositsioonid kahe või enama toimeainega aerosoolidele
BR0112969A (pt) Método de utilização de dicetopiperazinas e composições contendo-as
EA199900373A2 (ru) Фармацевтические композиции
DE50202328D1 (de) Amidofunktionelle aminopolydiorganosiloxane
HK1044349A1 (en) Compositions comprising 1,1,1,3,3-pentafluorobutane and use of said compositions.
RS50485B (sr) Terapeutske kombinacije koje sadrže amplodipin i atorvastatin
ATE231872T1 (de) Thiazolopyrimidinderivate
RS49723B (sr) Farmaceutska kompozicija koja sadrži entakapon ili nitekapon kao i umreženi derivat celuloze
HRP20000703B1 (en) Stabile compositions levosimendan and alginic acid
DE60005462D1 (de) Tintenzusammensetzungen enthaltend 1,3,5-Trioxan
ES2132539T3 (es) Composiciones insecticidas sinergicas.
MXPA03011128A (es) Composicion de sabor y fragancia.
HRP20000400B1 (en) Transmucosal formulations of levosimendal
TR199901017A3 (tr) Böcek ilaci terkibi.
BR9903981B1 (pt) compostos e composiÇÕes de fragrancia de metilciclotetradec-5-en-1-onas.
BR9916537B1 (pt) composição de fragráncia, e, produto.
RS50355B (sr) Formulacije eritropoietina sa više doza
MA26604A1 (fr) Compositions pharmaceutiques.
IT1307736B1 (it) Ossopiperazinil derivati e composizioni fotostabilizzate.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20100412

Year of fee payment: 12

PBON Lapse due to non-payment of renewal fee

Effective date: 20110424